CN114907242B - Synthesis method of 8-mercapto-6-oxooctanoic acid - Google Patents
Synthesis method of 8-mercapto-6-oxooctanoic acid Download PDFInfo
- Publication number
- CN114907242B CN114907242B CN202210613120.3A CN202210613120A CN114907242B CN 114907242 B CN114907242 B CN 114907242B CN 202210613120 A CN202210613120 A CN 202210613120A CN 114907242 B CN114907242 B CN 114907242B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- cuprous
- mercapto
- sulfide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- HQRJFGDWSDGOSF-UHFFFAOYSA-N SCCC(CCCCC(=O)O)=O Chemical compound SCCC(CCCCC(=O)O)=O HQRJFGDWSDGOSF-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000001308 synthesis method Methods 0.000 title claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 64
- -1 cyclohexane anhydride Chemical class 0.000 claims abstract description 26
- 239000007818 Grignard reagent Substances 0.000 claims abstract description 15
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 13
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 9
- 239000007858 starting material Substances 0.000 claims abstract description 8
- 238000005935 nucleophilic addition reaction Methods 0.000 claims abstract description 5
- 238000006845 Michael addition reaction Methods 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 3
- 239000011593 sulfur Substances 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 105
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 18
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims description 7
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims description 7
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 6
- RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 claims description 6
- 230000002194 synthesizing effect Effects 0.000 claims description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- IJMWREDHKRHWQI-UHFFFAOYSA-M magnesium;ethene;chloride Chemical compound [Mg+2].[Cl-].[CH-]=C IJMWREDHKRHWQI-UHFFFAOYSA-M 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 3
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 2
- MXZQOTDQZBUTHH-UHFFFAOYSA-M [I-].[Mg+]C=C Chemical compound [I-].[Mg+]C=C MXZQOTDQZBUTHH-UHFFFAOYSA-M 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- RFKZUAOAYVHBOY-UHFFFAOYSA-M copper(1+);acetate Chemical compound [Cu+].CC([O-])=O RFKZUAOAYVHBOY-UHFFFAOYSA-M 0.000 claims description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 2
- 229940045803 cuprous chloride Drugs 0.000 claims description 2
- ZOCLAPYLSUCOGI-UHFFFAOYSA-M potassium hydrosulfide Chemical compound [SH-].[K+] ZOCLAPYLSUCOGI-UHFFFAOYSA-M 0.000 claims description 2
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 claims description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 claims description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 claims description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 claims 1
- 238000009776 industrial production Methods 0.000 abstract description 11
- 238000010189 synthetic method Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 34
- 239000000243 solution Substances 0.000 description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 235000019136 lipoic acid Nutrition 0.000 description 16
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 16
- 239000012074 organic phase Substances 0.000 description 16
- 229960002663 thioctic acid Drugs 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000007792 addition Methods 0.000 description 9
- 238000004821 distillation Methods 0.000 description 9
- 230000007062 hydrolysis Effects 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 238000006722 reduction reaction Methods 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- 238000007363 ring formation reaction Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000000199 molecular distillation Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 229940048181 sodium sulfide nonahydrate Drugs 0.000 description 4
- WMDLZMCDBSJMTM-UHFFFAOYSA-M sodium;sulfanide;nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Na+].[SH-] WMDLZMCDBSJMTM-UHFFFAOYSA-M 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- HHCHLHOEAKKCAB-UHFFFAOYSA-N 2-oxaspiro[3.5]nonane-1,3-dione Chemical compound O=C1OC(=O)C11CCCCC1 HHCHLHOEAKKCAB-UHFFFAOYSA-N 0.000 description 3
- 238000006220 Baeyer-Villiger oxidation reaction Methods 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 238000005660 chlorination reaction Methods 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- CWINCVBWHUGBEB-UHFFFAOYSA-N 4-iodobutanenitrile Chemical compound ICCCC#N CWINCVBWHUGBEB-UHFFFAOYSA-N 0.000 description 2
- ABBAINNMPDQWIB-UHFFFAOYSA-N ClCCC(CCCCC(=O)O)=C=O Chemical compound ClCCC(CCCCC(=O)O)=C=O ABBAINNMPDQWIB-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 229940071870 hydroiodic acid Drugs 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- SZNILIWUUKKNPE-UHFFFAOYSA-N 2-nitrocyclohexan-1-one Chemical compound [O-][N+](=O)C1CCCCC1=O SZNILIWUUKKNPE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000012612 commercial material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- ZZWSNYNCRUZSPR-UHFFFAOYSA-N ethyl 2-(2-oxocyclohexyl)acetate Chemical compound CCOC(=O)CC1CCCCC1=O ZZWSNYNCRUZSPR-UHFFFAOYSA-N 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- SRRKNRDXURUMPP-UHFFFAOYSA-N sodium disulfide Chemical compound [Na+].[Na+].[S-][S-] SRRKNRDXURUMPP-UHFFFAOYSA-N 0.000 description 1
- 229940079101 sodium sulfide Drugs 0.000 description 1
- ZGHLCBJZQLNUAZ-UHFFFAOYSA-N sodium sulfide nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Na+].[Na+].[S-2] ZGHLCBJZQLNUAZ-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- FEONEKOZSGPOFN-UHFFFAOYSA-K tribromoiron Chemical compound Br[Fe](Br)Br FEONEKOZSGPOFN-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/083—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
The invention discloses a synthetic method of 8-mercapto-6-oxo-octanoic acid, belonging to the field of medicine synthesis and preparation. The synthesis method of the 8-mercapto-6-oxo octanoic acid is characterized by comprising the following synthesis steps: step 1), nucleophilic addition of a compound (I) cyclohexane anhydride serving as a starting material and a vinyl Grignard reagent to prepare a compound (II); step 2), the compound (II) reacts with sulfide and sulfur simple substance, and Michael addition is carried out to prepare the compound (III). The synthesis method of 8-mercapto-6-oxo-octanoic acid has the characteristics of low cost, simple operation, suitability for industrial production and the like.
Description
Technical Field
The invention relates to the technical field of medicine and intermediate synthesis, and relates to a method for synthesizing 8-mercapto-6-oxo-octanoic acid.
Background
The lipoic acid has a disulfide five-membered ring structure, has high charge density and is easy to generate free radical oxidation, thus having remarkable antioxidation capability and playing an antioxidation role through various mechanisms such as free radical removal or other antioxidant regeneration. In the medical field, lipoic acid is widely used for preventing and treating diabetes and related complications thereof; in the field of health products, lipoic acid is mainly used for removing free radicals in vivo, preventing lipid peroxidation, protecting cells from oxidative damage, and achieving the purposes of preventing and assisting in treating diseases. In addition to the above main uses, lipoic acid has a variety of potential applications in anti-tumor, treatment of inflammation, ischemia reperfusion injury, radiation injury, and acute and chronic liver diseases.
Lipoic acid has a large number of synthetic schemes, and the literature is reviewed as follows:
in 1957, donald s. acker et al used adipic monoester as a raw material and prepared lipoic acid through 7 steps of reaction such as acyl chlorination, addition, reduction, chlorination, cyclization, hydrolysis and acidification, wherein the yield of the route is only 20.88%, sodium disulfide is used in the cyclization reaction of the method, and the reaction is easy to generate a polymer, so that the quality of the product is reduced, and the reaction yield is affected.
In 1953, M.W. Bullock et al used 6-carbonyl-8-chlorooctanoate as a starting material to perform 6 steps of elimination, addition, reduction, hydrolysis, mercapto substitution, cyclization and the like to prepare lipoic acid, wherein the yield of lipoic acid is 17% from adipic acid monoethyl ester acyl chloride.
In 1954, lester J.Reed et al prepared lipoic acid from 6-carbonyl-8-chlorooctanoate by 4 steps of reduction, chlorination, cyclization, hydrolysis, acidification, etc. The process yield is not more than 30%, and the process needs to react with metal sodium in a liquid ammonia environment, so that the reaction is dangerous, needs a cryogenic reaction and is not suitable for large-scale production.
In 1957, august Segre et al used cyclohexanone as the starting material and produced lipoic acid by nine steps of condensation, coupling, carbonyl protection, reduction, acetylation, deprotection, baeyer-Villiger oxidation, sulfhydrylation, oxidation and the like, with a product yield of 20%. The whole synthesis route is longer, the steps are more, the operation is complicated, and the method is not suitable for industrialized mass production.
In 1999, wang Dun et al, university of Shenyang pharmacy, reported that the yield was 25% from cyclohexanone as the starting material by five steps of condensation, coupling, baeyer-Villiger oxidation, sulfhydrylation and oxidation.
Subhash P.Chavan et al used cyclohexanone and ethyl chloroacetate as raw materials and prepared lipoic acid through multiple steps of alkylation, elimination, reduction, cbz protection, oxidation, reduction, methylation, deprotection, ms protection, cyclization, hydrolysis and the like. The synthetic route is long and the yield is only 15%. The process uses explosive raw materials such as diazomethane, and the DIBAL-H needs to react at the low temperature of-78 ℃, and the series of factors make the method difficult to realize industrial production.
Maitreyee Bezbarua et al prepared methyl 6, 8-dihydroxyoctoate by 5 steps of reaction such as alkylation, ring opening, methylation, fermentation reduction and demethylation by using 2-nitrocyclohexanone as a raw material, and the yield is only 18%, so that industrial production cannot be truly carried out.
In 1989, aradamudan et al used acetoacetate and 4-iodobutyronitrile as raw materials and prepared by 7 steps of reactions such as alkylation, enzyme-catalyzed asymmetric hydrogenation, reduction, alcoholysis, ms protection, cyclization and hydrolysis. The process has long steps, the raw material 4-iodobutyronitrile is expensive, and the raw materials such as n-butyllithium, sodium hydrogen and the like are used, so that the method is extremely easy to burn and explode, is dangerous and is not suitable for industrial production.
In 1995, adger et al used ethyl 2-cyclohexanone acetate as a starting material and catalyzed (R) -enantiomer by monooxygenase (MO 2) to produce a selective Baeyer-Villiger oxidation reaction with a yield of 34% under optimal conditions. Then the (R) -alpha-lipoic acid is prepared through the reactions of ring opening, mitsunobu, hydrolysis, ms protection, cyclization, hydrolysis and the like. The raw materials in the route are expensive, the yield is low, the cost is high, and the method is not suitable for industrial production.
The existing synthetic routes have the defects of longer steps, high-price reagents, flammable and explosive hazardous reagents or production processes, special production equipment, serious environmental pollution and the like, and are not beneficial to large-scale industrial production.
Therefore, there is an urgent need for a method for preparing lipoic acid that is simple in reaction, low in cost, and ultimately easy for industrial production.
Disclosure of Invention
The invention aims to solve the technical problems that:
the 8-mercapto-6-oxo-octanoic acid synthesis method is easy to obtain raw materials, high in yield, good in quality, simple and convenient to operate and suitable for industrial production;
finally, the synthetic method for preparing the lipoic acid can also reach the requirements of high quality, high yield, simple and convenient operation and industrial production.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the specific synthesis process is as follows:
the synthesis method of the 8-mercapto-6-oxo-octanoic acid comprises the following synthesis steps:
step 1), nucleophilic addition of a compound (I) cyclohexane anhydride serving as a starting material and a vinyl Grignard reagent to prepare a compound (II);
step 2), the compound (II) reacts with sulfide and sulfur simple substance, and Michael addition is carried out to prepare a compound (III);
the reaction equations of steps 1) to 2) are as follows:
as a further improvement of the scheme, in the step 1), the compound (I) is used as a starting material and is subjected to nucleophilic addition with a vinyl Grignard reagent under the catalysis of a cuprous reagent to prepare the compound (II), the compound (I) and the vinyl Grignard reagent react in a solvent at the reaction temperature of-80-20 ℃, and the compound (II) or a solution thereof is obtained through post-treatment.
As a further improvement of the above scheme, in the step 1), the solvent is any one or more of tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether and dioxane.
As a further improvement of the scheme, in the step 1), the molar ratio of the cyclohexanedicarboxylic anhydride to the vinyl Grignard reagent is 1:0.9-3.0, and the vinyl Grignard reagent is any one or more of vinyl magnesium chloride, vinyl magnesium bromide and vinyl magnesium iodide.
As a further improvement of the above scheme, in step 1), the cuprous reagent is any one or more of cuprous iodide, cuprous chloride, cuprous bromide and cuprous acetate.
As a further improvement of the scheme, in the step 2), the compound (II) reacts with sulfide and elemental sulfur in an autoclave at an internal temperature of 60-200 ℃, and the compound (III) or a solution thereof is obtained by post-treatment, wherein the molar ratio of the compound (II), the sulfide and the elemental sulfur is 1:1.0 to 10.0:0.01 to 1.0.
As a further improvement of the above scheme, in step 2), the sulfide is any one or more of sodium sulfide, potassium sulfide, sodium hydrosulfide and potassium hydrosulfide.
As a further improvement of the scheme, the vinyl Grignard reagent in the step 1) is vinyl magnesium bromide, and the molar ratio of the cyclohexanedicarboxylic anhydride to the vinyl Grignard reagent is 1:1.0-1.2.
As a further improvement of the scheme, the cuprous reagent in the step 1) is cuprous iodide, and the molar ratio of the cyclohexanedicarboxylic anhydride to the cuprous reagent is 1:0.05-0.2.
As a further improvement of the above scheme, the reaction temperature in step 2) is 100 to 150 ℃, and the molar ratio of the compound (II), sulfide and elemental sulfur is 1:1.0 to 2.0:0.1 to 0.3.
The method for synthesizing lipoic acid provided by the invention has the following advantages:
1) The synthetic method of the 8-mercapto-6-oxo-octanoic acid has the advantages that the route is relatively simple, the raw materials are commercial materials, the raw materials are relatively cheap, no complex special operation is caused, and the synthetic method is suitable for industrial production;
2) The 8-mercapto-6-oxo-octanoic acid is prepared through the steps 1) and 2), and a new synthesis scheme is provided for the synthesis and preparation of lipoic acid;
3) The 8-mercapto-6-oxo-octanoic acid is prepared by the method, and the 8-mercapto-6-oxo-octanoic acid is prepared by the product 8-mercapto-6-oxo-octanoic acid, and the synthetic route has the advantages of easily available raw materials, higher yield, higher quality of the prepared product, simple operation and suitability for industrial production.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described below with reference to examples:
example 1:
into the reaction flask, 128.1g of cyclohexane anhydride (1 mol,1 eq), 600mL of tetrahydrofuran and 19.0g of cuprous iodide (0.1 mol,0.1 eq) were charged, cooled to-20℃and 600mL of 2M vinylmagnesium bromide (1.2 mol,1.2 eq) was added dropwise to the reaction solution, and the reaction was continued for 1 hour. After the reaction, the reaction solution is quenched by hydrochloric acid, filtered and layered. The organic phase layer is washed once with sodium chloride aqueous solution, the internal temperature is controlled below 50 ℃, the distillation is carried out under reduced pressure until no fraction is generated, and the crude product of the compound (II) is obtained and is directly put into the next reaction.
Taking the whole batch of the crude product of the compound (II), putting the batch into an autoclave, adding 288.2g of sodium sulfide nonahydrate solid (1.2 mol,1.2 eq), 0.64g of elemental sulfur (0.02 mol,0.02 eq) and 1000mL of water, heating to 110-120 ℃ and reacting for 5 hours. After the reaction is finished, cooling to room temperature, acidifying to pH 3-4 by adopting hydrochloric acid, extracting for 3 times by adopting tetrahydrofuran, merging organic phases, distilling until no fraction exists basically, adding 500g of methanol to obtain a methanol solution of the compound (III), and directly putting into the next reaction.
The methanol solution of the compound (III) in the previous step is cooled to-5 ℃, 37.8g of sodium borohydride (1.0 mol,1.0 eq) is added in portions, and after the addition is completed, the mixture is stirred for 1h. After the reaction, adding an ammonium chloride aqueous solution to quench the reaction. Distilled off methanol, added with tetrahydrofuran and sodium chloride aqueous solution, stirred for 30min, and layered. Extracting the water layer with tetrahydrofuran for 3 times, combining the organic phases, distilling under reduced pressure to a certain volume to obtain a compound (IV), and directly putting into the next reaction.
76.12g of thiourea (1.0 mol,1.0 eq) and 438.0g of 20% hydrochloric acid (2.4 mol,2.4 eq) were added to a reaction flask, the temperature was raised to 60℃and the compound (IV) solution obtained in the above step was slowly added dropwise to the reaction solution, and the reaction was carried out at 80℃for at least 10 hours after the completion of the dropwise addition. After the reaction was completed, 586.7g of 30% liquid alkali (4.4 mol,4.4 eq) was added, and the reaction was carried out by hydrolysis at 50℃for at least 2 hours. After the reaction, hydrochloric acid is adopted to adjust the pH value to 3-4, chloroform is adopted to extract for 3 times, the organic phases are combined, and half-saturated saline water is adopted to wash for 1 time. After distillation to no fraction, the residue was purified by molecular distillation to give 125.2g of compound (V), four-step reaction yield 60.1%, and nuclear magnetic data as follows: 1 H NMR(CDCl 3 ,400MHz) δ:2.93(m,1H),2.71(m,2H),2.38(t,2H),1.95-1.42(m,8H),1.35(t,1H),1.30(d,1H)。
104.2g of compound (V) (0.5 mol,1.0 eq) is added into a reaction bottle, 1000g of 2% sodium hydroxide aqueous solution is added, the pH is regulated to 8.8-9.2, 0.08g of ferric sulfate is added, the reaction temperature is controlled to be 20-30 ℃, oxygen is slowly introduced into the reaction system, and the reaction is carried out for more than 3 hours. After the reaction is finished, filtering, cooling the filtrate to 0-10 ℃, adopting hydrochloric acid to adjust the pH value to 1-2, and stirring for 2 hours. Filtering, drying the filter cake to dryness, recrystallizing with ethyl acetate and n-heptane, filtering, and drying to obtain 77.4g of product compound (VI), and collectingThe rate was 75.0%. The nuclear magnetic data are as follows: 1 H-NMR(CDCl 3 ,400MHz):δ=11.3ppm (s,1H);3.58(m,1H);3.18(t,2H);2.48(m,2H);1.3-2.30(m,8H)。
example 2:
into the reaction flask, 128.1g of cyclohexane anhydride (1 mol,1 eq), 600mL of tetrahydrofuran and 19.0g of cuprous iodide (0.1 mol,0.1 eq) were charged, cooled to-10℃and 525mL of 2M vinylmagnesium bromide (1.05 mol,1.05 eq) was added dropwise to the reaction solution, and the reaction was continued for 1 hour. After the reaction, the reaction solution is quenched by hydrochloric acid, filtered and layered. The organic phase layer is washed once with sodium chloride aqueous solution, the internal temperature is controlled below 50 ℃, the distillation is carried out under reduced pressure until no fraction is generated, and the crude product of the compound (II) is obtained and is directly put into the next reaction.
Taking the whole batch of the crude product of the compound (II), putting the batch into an autoclave, adding 360.3g of sodium sulfide nonahydrate solid (1.5 mol,1.5 eq), 0.64g of elemental sulfur (0.02 mol,0.02 eq) and 1000mL of water, heating to 110-120 ℃ and reacting for 5 hours. After the reaction is finished, cooling to room temperature, acidifying to pH 3-4 by adopting hydrochloric acid, extracting for 3 times by adopting tetrahydrofuran, merging organic phases, distilling until no fraction exists basically, adding 500g of methanol to obtain a methanol solution of the compound (III), and directly putting into the next reaction.
The methanol solution of the compound (III) in the previous step is cooled to-5 ℃, 41.6g of sodium borohydride (1.1 mol,1.1 eq) is added in portions, and after the addition is completed, the mixture is stirred for 1h. After the reaction, adding an ammonium chloride aqueous solution to quench the reaction. Distilled off methanol, added with tetrahydrofuran and sodium chloride aqueous solution, stirred for 30min, and layered. Extracting the water layer with tetrahydrofuran for 3 times, combining the organic phases, distilling under reduced pressure to a certain volume to obtain a compound (IV), and directly putting into the next reaction.
To the reaction flask was added 76.12g thiourea (1.0 mol, 1).0 eq) and 1534.8g of 20% hydroiodic acid (2.4 mol,2.4 eq), heating to 60 ℃, slowly adding dropwise the compound (IV) solution obtained in the above step into the reaction solution, heating to 80 ℃ for reaction for at least 10 hours after the dropwise addition is completed. After the reaction was completed, 586.7g of 30% liquid alkali (4.4 mol,4.4 eq) was added, and the reaction was carried out by hydrolysis at 50℃for at least 2 hours. After the reaction, hydrochloric acid is adopted to adjust the pH value to 3-4, chloroform is adopted to extract for 3 times, the organic phases are combined, and half-saturated saline water is adopted to wash for 1 time. After distillation to no fraction, the residue was purified by molecular distillation to give 131.7g of compound (V), four-step reaction yield 63.2%, and nuclear magnetic data as follows: 1 H NMR (CDCl 3 ,400MHz)δ:2.93(m,1H),2.71(m,2H),2.38(t,2H),1.95-1.42(m,8H), 1.35(t,1H),1.30(d,1H)。
104.2g of compound (V) (0.5 mol,1.0 eq) is added into a reaction bottle, 1000g of 2% sodium hydroxide aqueous solution is added, the pH is regulated to 8.8-9.2, 0.08g of ferric chloride is added, the reaction temperature is controlled to be 20-30 ℃, oxygen is slowly introduced into the reaction system, and the reaction is carried out for more than 3 hours. After the reaction is finished, filtering, cooling the filtrate to 0-10 ℃, adopting hydrochloric acid to adjust the pH value to 1-2, and stirring for 2 hours. After filtration and drying of the filter cake to dryness, recrystallization from ethyl acetate and n-heptane, filtration and drying gave 78.9g of the product compound (VI) in a yield of 76.5%. The nuclear magnetic data are as follows: 1 H-NMR(CDCl 3 ,400MHz):δ=11.3ppm (s,1H);3.58(m,1H);3.18(t,2H);2.48(m,2H);1.3-2.30(m,8H)。
example 3:
into the reaction flask, 128.1g of cyclohexane anhydride (1 mol,1 eq), 600mL of tetrahydrofuran and 19.0g of cuprous iodide (0.1 mol,0.1 eq) were added, the temperature was lowered to-20℃and 600mL of 2M vinyl magnesium chloride (1.2 mol,1.2 eq) was added dropwise to the reaction solution, followed by thermal insulation reaction for 1 hour. After the reaction, the reaction solution is quenched by hydrochloric acid, filtered and layered. The organic phase layer is washed once with sodium chloride aqueous solution, the internal temperature is controlled below 50 ℃, the distillation is carried out under reduced pressure until no fraction is generated, and the crude product of the compound (II) is obtained and is directly put into the next reaction.
Taking the whole batch of the crude product of the compound (II), putting the batch into an autoclave, adding 288.2g of sodium sulfide nonahydrate solid (1.2 mol,1.2 eq), 1.6g of elemental sulfur (0.05 mol,0.05 eq) and 1000mL of water, heating to 130-140 ℃ and reacting for 4 hours. After the reaction is finished, cooling to room temperature, acidifying to pH 3-4 by adopting hydrochloric acid, extracting for 3 times by adopting tetrahydrofuran, merging organic phases, distilling until no fraction exists basically, adding 500g of ethanol to obtain an ethanol solution of the compound (III), and directly putting into the next reaction.
The ethanol solution of the compound (III) in the previous step is cooled to-5 ℃, 21.8g of lithium borohydride (1.0 mol,1.0 eq) is added in portions, and after the addition is completed, the mixture is stirred for 1h. After the reaction, adding an ammonium chloride aqueous solution to quench the reaction. Distilling off B, adding tetrahydrofuran and sodium chloride aqueous solution, stirring for 30min, and layering. Extracting the water layer with tetrahydrofuran for 3 times, combining the organic phases, distilling under reduced pressure to a certain volume to obtain a compound (IV), and directly putting into the next reaction.
76.12g of thiourea (1.0 mol,1.0 eq) and 1534.8g of 20% hydroiodic acid (2.4 mol,2.4 eq) were added to the reaction flask, the temperature was raised to 60℃and the solution of the compound (IV) obtained in the above step was slowly added dropwise to the reaction solution, and the reaction was carried out at 80℃for at least 10 hours after the completion of the dropwise addition. After the completion of the reaction, 822.8g of 30% aqueous potassium hydroxide (4.4 mol,4.4 eq) was added, and the hydrolysis reaction was carried out at 50℃for at least 2 hours. After the reaction, hydrochloric acid is adopted to adjust the pH value to 3-4, chloroform is adopted to extract for 3 times, the organic phases are combined, and half-saturated saline water is adopted to wash for 1 time. After distillation to no fraction, the residue was purified by molecular distillation to prepare 122.5g of compound (V), 58.8% in four-step reaction yield, and the nuclear magnetic data were as follows: 1 H NMR(CDCl 3 ,400MHz)δ:2.93(m,1H),2.71(m,2H),2.38(t,2H),1.95-1.42(m, 8H),1.35(t,1H),1.30(d,1H)。
into a reaction flask, 104.2g of Compound (V) (0.5 mol,1.0 eq) was charged, and 1402.5g of 2% aqueous potassium hydroxide solution was added to adjust the pH to 8.8About 9.2 g of ferric bromide is added, the reaction temperature is controlled to be 20-30 ℃, oxygen is slowly introduced into the reaction system, and the reaction is carried out for more than 3 hours. After the reaction is finished, filtering, cooling the filtrate to 0-10 ℃, adopting hydrochloric acid to adjust the pH value to 1-2, and stirring for 2 hours. After filtration and drying of the filter cake to dryness, recrystallization from ethyl acetate and n-heptane, filtration and drying gave 75.5g of the product compound (VI) in 73.2% yield. The nuclear magnetic data are as follows: 1 H-NMR(CDCl 3 ,400MHz):δ=11.3ppm (s,1H);3.58(m,1H);3.18(t,2H);2.48(m,2H);1.3-2.30(m,8H)。
example 4:
128.1g of cyclohexane anhydride (1 mol,1 eq) and 600mL of 2-methyltetrahydrofuran and 14.3g of cuprous bromide (0.1 mol,0.1 eq) were added to the reaction flask, the temperature was lowered to-20℃and 550mL of 2M vinyl magnesium chloride (1.1 mol,1.1 eq) was added dropwise to the reaction solution, and the reaction was continued for 1 hour. After the reaction, the reaction solution is quenched by hydrochloric acid, filtered and layered. The organic phase layer is washed once with sodium chloride aqueous solution, the internal temperature is controlled below 50 ℃, the distillation is carried out under reduced pressure until no fraction is generated, and the crude product of the compound (II) is obtained and is directly put into the next reaction.
Taking the whole batch of the crude product of the compound (II), putting the batch into an autoclave, adding 336.2g of sodium sulfide nonahydrate solid (1.4 mol,1.4 eq), 0.64g of elemental sulfur (0.02 mol,0.02 eq) and 1000mL of water, heating to 110-120 ℃ and reacting for 5 hours. After the reaction is finished, cooling to room temperature, acidifying to pH 3-4 by adopting hydrochloric acid, extracting for 3 times by adopting 2-methyltetrahydrofuran, merging organic phases, distilling until no fraction is basically generated, adding 500g of methanol to obtain a methanol solution of the compound (III), and directly putting into the next reaction.
The methanol solution of the compound (III) in the previous step was cooled to-5 to 5℃and 53.9g of potassium borohydride (1.0 mol,1.0 eq) was added in portions, followed by stirring for 1 hour. After the reaction, adding an ammonium chloride aqueous solution to quench the reaction. Methanol was distilled off, 2-methyltetrahydrofuran and aqueous sodium chloride solution were added, stirred for 30min, and the layers were separated. The aqueous layer is extracted for 3 times by adopting 2-methyltetrahydrofuran, the organic phases are combined, reduced pressure distillation is carried out to a certain volume, and the compound (IV) is obtained and directly put into the next reaction.
114.2g of thiourea (1.5 mol,1.5 eq) and 809.0g of 20% hydrobromic acid (2.0 mol,2.0 eq) were added to a reaction flask, the temperature was raised to 60℃and the solution of the compound (IV) obtained in the above step was slowly added dropwise to the reaction solution, and the reaction was carried out at 80℃for at least 10 hours after the completion of the dropwise addition. After the completion of the reaction, 822.8g of 30% aqueous potassium hydroxide (4.4 mol,4.4 eq) was added, and the hydrolysis reaction was carried out at 50℃for at least 2 hours. After the reaction, hydrochloric acid is adopted to adjust the pH value to 3-4, chloroform is adopted to extract for 3 times, the organic phases are combined, and half-saturated saline water is adopted to wash for 1 time. After distillation to no fraction, the residue was purified by molecular distillation to give 117.3g of compound (V), four-step reaction yield 56.3%, and nuclear magnetic data as follows: 1 H NMR (CDCl 3 ,400MHz)δ:2.93(m,1H),2.71(m,2H),2.38(t,2H),1.95-1.42(m,8H), 1.35(t,1H),1.30(d,1H)。
104.2g of compound (V) (0.5 mol,1.0 eq) is added into a reaction bottle, 1000g of 2% sodium hydroxide aqueous solution is added, the pH is regulated to 8.8-9.2, 0.20g of ferric chloride is added, the reaction temperature is controlled to be 20-30 ℃, oxygen is slowly introduced into the reaction system, and the reaction is carried out for more than 3 hours. After the reaction is finished, filtering, cooling the filtrate to 0-10 ℃, adopting hydrochloric acid to adjust the pH value to 1-2, and stirring for 2 hours. After filtration and drying of the cake to dryness, recrystallization from ethyl acetate and n-heptane, filtration and drying gave 80.5g of the product compound (VI) in 78.0% yield. The nuclear magnetic data are as follows: 1 H-NMR(CDCl 3 ,400MHz):δ=11.3ppm (s,1H);3.58(m,1H);3.18(t,2H);2.48(m,2H);1.3-2.30(m,8H)。
Claims (5)
1. a synthesis method of 8-mercapto-6-oxo-octanoic acid, which is characterized by comprising the following synthesis steps:
step 1), nucleophilic addition of a compound (I) cyclohexane anhydride serving as a starting material and a vinyl Grignard reagent to prepare a compound (II);
step 2), the compound (II) reacts with sulfide and sulfur simple substance, and Michael addition is carried out to prepare a compound (III);
the reaction equation of steps 1) to 2) is as follows:
;
in the step 1), the compound (I) is taken as an initial raw material, and is subjected to nucleophilic addition with a vinyl Grignard reagent under the catalysis of a cuprous reagent to prepare a compound (II), the compound (I) and the vinyl Grignard reagent react in a solvent at the reaction temperature of-80-20 ℃, and the compound (II) or a solution thereof is obtained through post-treatment;
in the step 2), the compound (II) reacts with sulfide and elemental sulfur in an autoclave at an internal temperature of 60-200 ℃, and the compound (III) or a solution thereof is prepared by post-treatment, wherein the molar ratio of the compound (II), the sulfide and the elemental sulfur is 1:1.0 to 10.0:0.01 to 1.0;
in the step 1), the molar ratio of the cyclohexane anhydride to the vinyl Grignard reagent is 1:0.9-3.0, wherein the vinyl Grignard reagent is any one or more of vinyl magnesium chloride, vinyl magnesium bromide and vinyl magnesium iodide;
in the step 1), the cuprous reagent is any one or more of cuprous iodide, cuprous chloride, cuprous bromide and cuprous acetate;
in the step 2), the sulfide is any one or more of sodium sulfide, potassium sulfide, sodium hydrosulfide and potassium hydrosulfide.
2. The method for synthesizing 8-mercapto-6-oxooctanoic acid according to claim 1, wherein in step 1), the solvent is any one or more of tetrahydrofuran, 2-methyltetrahydrofuran, methyl tert-butyl ether, dioxane.
3. The method for synthesizing 8-mercapto-6-oxooctanoic acid according to claim 1, wherein the vinyl grignard reagent in the step 1) is vinyl magnesium bromide, and the molar ratio of the cyclohexane anhydride to the vinyl grignard reagent is 1:1.0-1.2.
4. The method for synthesizing 8-mercapto-6-oxooctanoic acid according to claim 1, wherein the cuprous reagent in step 1) is cuprous iodide, and the molar ratio of the cyclic anhydride to the cuprous reagent is 1:0.05-0.2.
5. The method for synthesizing 8-mercapto-6-oxooctanoic acid according to claim 1, wherein in the step 2), the reaction temperature is 100-150 ℃, and the molar ratio of the compound (II), sulfide and elemental sulfur is 1:1.0 to 2.0:0.1 to 0.3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210613120.3A CN114907242B (en) | 2022-05-31 | 2022-05-31 | Synthesis method of 8-mercapto-6-oxooctanoic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210613120.3A CN114907242B (en) | 2022-05-31 | 2022-05-31 | Synthesis method of 8-mercapto-6-oxooctanoic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114907242A CN114907242A (en) | 2022-08-16 |
CN114907242B true CN114907242B (en) | 2023-11-07 |
Family
ID=82770117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210613120.3A Active CN114907242B (en) | 2022-05-31 | 2022-05-31 | Synthesis method of 8-mercapto-6-oxooctanoic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114907242B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2828321A (en) * | 1953-10-19 | 1958-03-25 | American Cyanamid Co | Keto aliphatic acid esters and method of preparing the same |
WO2011034364A2 (en) * | 2009-09-17 | 2011-03-24 | 에스케이케미칼 주식회사 | Method for preparing high-purity n,n'-disubstituted-3,3'-dithiodipropionamides |
CN110372551A (en) * | 2019-08-15 | 2019-10-25 | 河北霍夫曼新材料科技有限公司 | The preparation method of 3- mercaptopropionic acid |
-
2022
- 2022-05-31 CN CN202210613120.3A patent/CN114907242B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2828321A (en) * | 1953-10-19 | 1958-03-25 | American Cyanamid Co | Keto aliphatic acid esters and method of preparing the same |
WO2011034364A2 (en) * | 2009-09-17 | 2011-03-24 | 에스케이케미칼 주식회사 | Method for preparing high-purity n,n'-disubstituted-3,3'-dithiodipropionamides |
CN110372551A (en) * | 2019-08-15 | 2019-10-25 | 河北霍夫曼新材料科技有限公司 | The preparation method of 3- mercaptopropionic acid |
Non-Patent Citations (1)
Title |
---|
Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα;Chiara Borsari等;Journal of the American Chemical Society;第第144卷卷;第6326-6342页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114907242A (en) | 2022-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112608296B (en) | Synthesis method of Brazilane natural product Brazilane | |
CN103827075A (en) | Preparation method of 1-palmitoyl-3-acetylglycerol, and preparation method of 1-palmitoyl-2-linoleoyl-3-acetylglycerol using same | |
CN109096122B (en) | Process for preparing spermidine | |
CN114907242B (en) | Synthesis method of 8-mercapto-6-oxooctanoic acid | |
CN114560901A (en) | Preparation method of ergosterol or derivative thereof | |
CN114874184B (en) | Method for synthesizing lipoic acid | |
CN108911954B (en) | Preparation method of trimethylhydroquinone | |
CN113248468B (en) | 12-crown ether-4 lithium salt complex and preparation method and application thereof | |
CN113582821B (en) | Preparation method of 8-methyldecanal | |
CN114920639B (en) | Novel method for synthesizing curcumin analogues | |
CN110128246B (en) | Preparation method of hydroxytyrosol | |
CN106831671A (en) | A kind of preparation method of vitamine C palmitate | |
CN114456146A (en) | Method for synthesizing watermelon ketone | |
CN109761868B (en) | Synthesis method of optically pure chlorprostenol | |
CN217578737U (en) | Synthetic system is used in lipoic acid preparation | |
CN117402104A (en) | Preparation method of chiral intermediate of atorvastatin | |
CN113354521A (en) | Preparation method of 2-methoxy-5-fluoro bromoacetophenone | |
CN115716817B (en) | Preparation method of 6, 8-cyclotristhioctic acid | |
CN111793047A (en) | Preparation method of eribulin intermediate | |
CN115536494B (en) | Synthesis method of 1- (4-bromophenyl) -1, 4-butanediol | |
KR101699262B1 (en) | Manufacturing Method of Alpha-Arbutin | |
CN113666903B (en) | Preparation method of sesamol | |
CN116199570B (en) | Preparation method of 2, 7-dimethyl-2, 4, 6-octatriene-1, 8-dialdehyde | |
CN113416142B (en) | Preparation method of 5-ALA intermediate 5-bromolevulinate | |
KR102333606B1 (en) | Method for producing 1-palmitoyl-2-linoleoyl-3-acetyl glycerol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |